JIN YONG LEE: Open Payments
NPI 1699439356 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$265 in 8 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $730 · 2025 $265
Food & beverage: $265
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 1 | $86 |
| Novartis Pharmaceuticals Corporation | 2 | $54 |
| Deciphera Pharmaceuticals Inc. | 2 | $47 |
| Solventum Corporation | 1 | $30 |
| Incyte Corporation | 1 | $28 |
| Celgene Corporation | 1 | $21 |
Products named: ADCETRIS, SCEMBLIX, QINLOCK, V.A.C.ULTA, JAKAFI, REBLOZYL.
Industry payments across CA — which companies pay providers there.
